{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/973662120",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1241014644"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#973662120",
  "code": "KA84.2",
  "source": "http://id.who.int/icd/entity/973662120",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "ABO isoimmunization of fetus or newborn"
  },
  "definition": {
    "@language": "en",
    "@value": "A condition of the newborn characterized by the destruction of red blood cells initiated by the transmission of anti-A or anti-B antibodies from a mother to the child via the placenta against A or B antigens of the newborn's blood."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "ABO isoimmunization of fetus or newborn"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "ABO haemolytic disease"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "ABO immunisation, affecting management of pregnancy, in fetus or newborn"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "ABO incompatibility, fetus or newborn"
      }
    }
  ]
}